© 2017, Xoft, a subsidiary of iCAD Inc.  All rights reserved.  Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc..

Pre-book your presentation or demonstration today.

Patients diagnosed with NMSC, such as basal or squamous cell carcinoma, may have concerns about scarring, wound healing or preserving functionality in anatomically challenging areas.
 

Discover skin eBx, a non-invasive alternative to surgery for non-melanoma skin cancer (NMSC) treatment.

From the market leader in skin electronic brachytherapy, skin eBx provides a safe, effective,
patient-friendly option for NMSC treatment, with excellent clinical and cosmetic results.1
 
By delivering a precise dose of targeted radiation directly to the area, skin eBx offers suitable patients a non-surgical, scar-free solution while limiting exposure to surrounding healthy tissue.
 
With treatment delivered in just a few brief office visits, skin eBx provides a convenient option allowing patients to return to normal activities immediately with no downtime. More than 10,000 NMSC patients have been successfully treated with skin eBx.

Join us at table 14 to explore the unique and valuable benefits this innovative technology can offer to you, your practice and your patients.

 

 
1. A Bhatnagar, et al. High-dose Rate Electronic Brachytherapy: A Nonsurgical Treatment Alternative for Nonmelanoma Skin Cancer. The Journal of Clinical and Aesthetic Dermatology; Nov. 2016; Vol.9; No.11: 16

Squamous cell carcinoma 
Treated with 40 Gy to a 3 mm depth

Pre-Treatment

One Year